Open original FDA record ↗Recall record
- FDA identifier
- Z-1299-2021
- Company in FDA record
- Meridian Bioscience Inc
- FDA record creation date
- Mar 24, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.
Source facts
- Action
- On 02/19/2021, Meridian issued an Urgent Medical Device Correction notice to customers via letter for ImmunoCard Mycoplasma kits from a specified lot. Upon receipt at the Cardinal Health Charlotte distribution center, the kits were identified to have a transit time of 115 hours with a maximum temperature of 55 F (approximately 12 C). This is beyond our transit time requirement of 72 hours and storage at 2-8 C. Cardinal placed the kits into a quarantine location, however 8 kits were inadvertently shipped to your facility.
- Initiated
- 2021-02-08
- Root cause
- Storage
- Terminated
- 2021-10-26
- Distribution
- US Nationwide distribution in the states of OH, SC.
- Recall number
- Z-1299-2021
- Recall status
- Terminated
- CDRH record ID
- 186011
- FDA record created
- 2021-03-24
- Recall event number
- 87430